Clinical Trials Sponsored by Allegheny Health Network Research Institute

Total 7573 results

SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery (S0931)

Kidney Cancer

United States, Puerto Rico
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer

Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

Nausea | Constipation | Diarrhea | Purpura | Lymphadenopathy | Gastrointestinal Hemorrhage | Hepatomegaly | Primary Systemic Amyloidosis | Amorphous, Eosinophilic, and Acellular Deposit | Early Satiety | Macroglossia | Recurrent Primary Amyloidosis | Refractory Primary Amyloidosis

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Advanced Lung Non-Squamous Non-Small Cell Carcinoma | Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States, Colombia, Mexico, Chile
SWOG Cancer Research Network
National Cancer Institute (NCI)

Completed

Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer

Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Completed

Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7

United States, Canada
SWOG Cancer Research Network
National Cancer Institute (NCI)

Completed

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer (COXEN)

Bladder Cancer

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Completed

S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia

Leukemia

United States
Santhera Pharmaceuticals
European Vision Institute Clinical Research Network

Completed

Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey

Leber Hereditary Optic Neuropathy (LHON)

Belgium, France, Denmark, Italy, Slovenia
H. Lee Moffitt Cancer Center and Research Institute
Florida Department of Health; Health Choice Network

Recruiting

HPV Multilevel Intervention Strategies Targeting Immunization in Community Settings (HPV MISTICS) (HPV MISTICS)

Human Papilloma Virus (HPV) Vaccine

United States
Bruyere Research Institute
Canadian Institutes of Health Research (CIHR)

Unknown

The PIP-STOPP Study (PIP-STOPP)

Potentially Inappropriate Prescribing (PIP)
AusculSciences Canada Inc.
University of Calgary; Hamilton Health Sciences Corporation; Ottawa Heart Institute... and other collaborators

Suspended

Evaluation of the CAD-det System, a Novel Non-Invasive Acoustic Diagnostic for the Diagnosis of Coronary Artery Disease (CAD-det)

Coronary Artery Disease | Cardiovascular Disease

Canada
McGill University Health Centre/Research Institute...
Canadian Institutes of Health Research (CIHR); Canadian Frailty Network; Canadian...

Recruiting

Understanding the Negative Effects of Bed Rest and Using Exercise as Countermeasure

Aging

Canada
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR); Medtronic

Completed

Resynchronization/Defibrillation for Ambulatory Heart Failure Trial (RAFT)

Heart Failure, Congestive

Canada, Netherlands, Australia, Turkey, Denmark, Germany, Belgium
National Heart, Lung, and Blood Institute (NHLBI)
Asthma Clinical Research Network

Completed

Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT

Lung Diseases | Asthma
NICHD Neonatal Research Network
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants (Darbe)

Neonatal | Neurodevelopmental Impairment | Neurocognitive | Neuroprotective

United States
University of British Columbia
Canadian Institutes of Health Research (CIHR); PHAC/CIHR Influenza Research...

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young Children

Influenza

Canada
University Health Network, Toronto
Canadian Breast Cancer Research Alliance

Completed

Effects of Exemestane on Bone Strength (MAP3BSS)

Breast Cancer | Osteoporosis

United States, Canada
University Health Network, Toronto
Canadian National Transplant Research Program

Completed

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients (QFT-CMV)

Cytomegalovirus Viraemia

Spain, Canada
University Health Network, Toronto
Glaucoma Research Society of Canada

Completed

Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression

Ocular Hypertension | Glaucoma

Canada
University of Toronto
University Health Network, Toronto; Thornhill Research

Unknown

The Response of Intraocular Pressure to Systemic Hypercapnia and Hyperoxia

Intraocular Pressure

Canada
Ottawa Hospital Research Institute
Ontario HIV Treatment Network; CIHR Canadian HIV Trials Network

Completed

Micronutrients and Antioxidants in HIV Infection (MAINTAIN)

HIV Infection

Canada
University Health Network, Toronto
The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); University of Toronto and other collaborators

Active, not recruiting

The Canadian COVID-19 Prospective Cohort Study (CANCOV)

Covid19

Canada
University Health Network, Toronto
Glaucoma Research Society of Canada

Completed

Nasal Steroids in Controlled Glaucoma

Intraocular Pressure

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Head and Neck Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Tipifarnib, Cytarabine, and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia

Leukemia

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Canada
Kirby Institute
Justice Health & Forensic Mental Health Network NSW Australia

Completed

Prisons Evaluation of a One-stop-shop InterVentiOn (PIVOT)

Hepatitis C

Australia
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer

Prostate Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer (NCI 8076)

Unspecified Adult Solid Tumor, Protocol Specific

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer

Pancreatic Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

UCN-01 and Topotecan in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Perifosine in Treating Patients With Advanced Pancreatic Cancer

Pancreatic Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer

Colorectal Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter

Bladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter

United States, Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Perifosine in Treating Patients With Recurrent, Refractory, Locally Advanced, or Metastatic Breast Cancer

Breast Cancer

Canada
NICHD Neonatal Research Network
Canadian Institutes of Health Research (CIHR); National Center for Research... and other collaborators

Terminated

Early Inhaled Nitric Oxide for Respiratory Failure in Newborns (Early iNO)

Respiratory Insufficiency | Hypertension, Pulmonary | Pneumonia, Aspiration | Persistent Fetal Circulation Syndrome | Respiratory Distress Syndrome, Newborn | Infant, Newborn

United States
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Imatinib Mesylate in Treating Patients With Salivary Gland Cancer

Head and Neck Cancer

United States, Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Terminated

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Sarcoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Prostate Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)

Liver Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Sorafenib and Erlotinib in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma

Lymphoma | Leukemia

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Bladder Cancer

United States, Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Cancer

Canada
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Vorinostat and Capecitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

Canada
The Mediterranean Institute for the Advance of...
Carlos III Health Institute; Andaluz Health Service; Preventive Services and...

Completed

Primary Prevention of Major Depression Based on the Level and Profile of Risk of Primary Care Attenders: Cluster, Controlled, Randomised Trial (predictD-CCRT)

Depression

Spain
University Health Network, Toronto
Canadian Foundation for AIDS Research (CANFAR); Ontario HIV Treatment Network

Completed

Screening for HIV-Associated Anal Cancer (TRACE)

HIV Infections | Papillomavirus Infections | Anal Cancer | Anal Dysplasia

Canada
Women's College Hospital
University Health Network, Toronto; Canadian Institutes of Health Research... and other collaborators

Recruiting

Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial (SPRINTR)

Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Keratinocyte Carcinoma | Non-melanoma Skin Cancer

Canada

Clinical Trials Sponsored by Allegheny Health Network Research Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Iran

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations